- Home
- GLSI vs STRS Comparison
GLSI vs STRS Comparison
Compare GLSI & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- STRS
- Stock Information
- Founded
- GLSI 2006
- STRS 1992
- Country
- GLSI United States
- STRS United States
- Employees
- GLSI N/A
- STRS N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- STRS Homebuilding
- Sector
- GLSI Health Care
- STRS Real Estate
- Exchange
- GLSI Nasdaq
- STRS Nasdaq
- Market Cap
- GLSI 134.6M
- STRS 155.7M
- IPO Year
- GLSI 2020
- STRS N/A
- Fundamental
- Price
- GLSI $10.08
- STRS $18.38
- Analyst Decision
- GLSI Strong Buy
- STRS
- Analyst Count
- GLSI 1
- STRS 0
- Target Price
- GLSI $39.00
- STRS N/A
- AVG Volume (30 Days)
- GLSI 54.6K
- STRS 22.0K
- Earning Date
- GLSI 08-13-2025
- STRS 08-12-2025
- Dividend Yield
- GLSI N/A
- STRS N/A
- EPS Growth
- GLSI N/A
- STRS N/A
- EPS
- GLSI N/A
- STRS N/A
- Revenue
- GLSI N/A
- STRS $32,719,000.00
- Revenue This Year
- GLSI N/A
- STRS N/A
- Revenue Next Year
- GLSI N/A
- STRS N/A
- P/E Ratio
- GLSI N/A
- STRS N/A
- Revenue Growth
- GLSI N/A
- STRS N/A
- 52 Week Low
- GLSI $8.06
- STRS $15.10
- 52 Week High
- GLSI $17.00
- STRS $30.66
- Technical
- Relative Strength Index (RSI)
- GLSI 53.55
- STRS 48.72
- Support Level
- GLSI $8.97
- STRS $18.71
- Resistance Level
- GLSI $11.52
- STRS $21.01
- Average True Range (ATR)
- GLSI 0.53
- STRS 0.97
- MACD
- GLSI 0.14
- STRS -0.04
- Stochastic Oscillator
- GLSI 49.53
- STRS 28.57
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.